Baldwin Brothers LLC Regeneron Pharmaceuticals, Inc. Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 3 shares of REGN stock, worth $2,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$2,286

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$1024.09 - $1201.76 $3,072 - $3,605	3 New	3 $3,000
Q1 2023 Apr 21, 2023	SELL	$680.49 - $826.97 $74,853 - $90,966	-110 Reduced 69.18%	49 $40,000
Q4 2022 Jan 27, 2023	SELL	$705.89 - $766.39 $137,648 - $149,446	-195 Reduced 55.08%	159 $0
Q3 2022 Oct 14, 2022	SELL	$573.97 - $724.32 $14,923 - $18,832	-26 Reduced 6.84%	354 $244,000
Q2 2022 Jul 18, 2022	SELL	$548.35 - $738.84 $310,914 - $418,922	-567 Reduced 59.87%	380 $225,000
Q1 2022 Apr 13, 2022	SELL	$595.12 - $698.43 $7.53 Million - $8.84 Million	-12,661 Reduced 93.04%	947 $661,000
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $429,892 - $530,737	791 Added 6.17%	13,608 $8.59 Million
Q3 2021 Oct 27, 2021	BUY	$574.03 - $680.96 $358,768 - $425,600	625 Added 5.13%	12,817 $7.76 Million
Q2 2021 Jul 30, 2021	BUY	$472.8 - $558.54 $218,433 - $258,045	462 Added 3.94%	12,192 $6.81 Million
Q1 2021 Apr 08, 2021	BUY	$446.73 - $548.2 $176,458 - $216,539	395 Added 3.48%	11,730 $5.55 Million
Q4 2020 Jan 12, 2021	BUY	$478.3 - $607.98 $1.55 Million - $1.98 Million	3,251 Added 40.22%	11,335 $5.48 Million
Q3 2020 Oct 16, 2020	BUY	$544.75 - $658.21 $1.11 Million - $1.34 Million	2,036 Added 33.66%	8,084 $4.53 Million
Q2 2020 Jul 21, 2020	BUY	$493.32 - $643.92 $221,007 - $288,476	448 Added 8.0%	6,048 $3.77 Million
Q1 2020 Apr 15, 2020	BUY	$336.18 - $494.43 $1.88 Million - $2.77 Million	5,600 New	5,600 $2.73 Million

Others Institutions Holding REGN

# of Institutions

1,530

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Regeneron Pharmaceuticals, Inc. Transaction History